Inhibiting NF-κB activation by small molecules as a therapeutic strategy
Top Cited Papers
- 21 May 2010
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1799 (10-12), 775-787
- https://doi.org/10.1016/j.bbagrm.2010.05.004
Abstract
No abstract availableKeywords
This publication has 227 references indexed in Scilit:
- Negative regulation of NF-κB action by Set9-mediated lysine methylation of the RelA subunitThe EMBO Journal, 2009
- Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-κB activation during infectionVirology, 2008
- Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-κB signal pathwaysExperimental and Molecular Pathology, 2008
- Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κBMolecular Cell, 2007
- Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significanceOncogene, 2006
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- NF-κB, chemokine gene transcription and tumour growthNature Reviews Immunology, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NF‐κB is involved in the survival of cerebellar granule neurons: association of Iκβ phosphorylation with cell survivalJournal of Neurochemistry, 2001
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999